Admittance Technologies Awarded Innovation Abstract at Heart Rhythm Society 2012

cardiovol vs biotronik

BOSTON, MA – May 25, 2012 – Admittance Technologies announces today that it received an Innovation Award at the 33rd annual Scientific Sessions of the Heart Rhythm Society on May 10th. The Heart Rhythm Society showcases “the latest science, discovery and innovation that are essential to quality care for patients” and is the premiere conference targeting cardiac arrhythmia experts.

Dr. Marc Feldman, CEO of Admittance Technologies, presented an abstract entitled “Monitoring LV Stroke Volume During Simulated Ventricular Tachycardia from Bi-V Pacing Leads,” in poster session. Implanted Defibrillators (ICDs) monitor heart rhythms in patients and respond to cardiac arrhythmias with the delivery of a life-saving shock. However, inappropriate shocks are delivered to one third of patients within the first 1-3 years. The presented abstract addresses this problem with Admittance Technology’s flagship product, CardioVol™.

CardioVol™ is a combined software/firmware solution that allows real-time blood volume measurement using existing pacemaker leads, and enclosures. Feldman notes “The strength of this technology, is that no additional surgery is required, allowing implantation to be transparent to both doctor and patient.”

Admittance Technologies had meetings with all four of the major pacemaker companies including St. Jude Medical, Medtronic, Biotronik, and Boston Scientific while at the Scientific Sessions.